Visit with the Executive Director of UNAIDS to see non-surgical circumcision in the Nyamata Distict Hospital in the East Province of Rwanda

On 16 March, we had the great pleasure of accompanying the Executive Director of UNAIDS, Michel Sidibe on a visit to the Nyamata Distict Hospital in the East Province of Rwanda. We went to see a major revolution in the global fight against HIV, showcasing PrePex - a new non-surgical device for circumcision that allows health care providers to perform each procedure in fewer than 3 minutes without anesthesia, without blood and without suture.

Michel Sidibé traveled to the Nyamata District Hospital after visiting His Excellency President Paul Kagame in Uruguiro. According the New Times – a daily journal in Rwanda – Michel Sidibe said, “President Kagame’s leadership and vision demonstrate clearly that we can produce results when you have commitment at the higher levels.” This applies to the fight against HIV and AIDS.

He spoke with the journalists about the research we have done on Prepex to and affirm our goal to perform 2 million male circumcisions using this new technology nationwide which will revolutionize HIV prevention in Rwanda.

The PrePex device includes an elastic band that fits around an inner ring, to trap the foreskin of the penis, in order to stop the blood flow in the foreskin. The dry foreskin is than removed after one week, (See the blog post March). For the first time, this action can be done on a massive scale for men and will support the prevention of HIV infection not only through the procedure, but also through HIV counseling and testing along with condom distribution and use sensitization of men waiting to be circumcised.

Miche Sidibe said how he was impressed and promise to be the champion of the utilization of this innovation that takes less than 3 minutes to perform and reduces the risk of HIV infection by 66%.

Male circumcision at different ages in Rwanda. A cost-effectiveness study.

Friday, March 11, 2011

There is strong evidence in favour of MC to reduce HIV infection and other STI. In Rwanda, where adult HIV prevalence is 3%, MC is not a traditional practice. To inform policy and programmatic decisions in relation to introducing MC, the Rwanda National AIDS Commission modelled cost and effects of MC at different ages. This study was needed given that the MC debate in Southern Africa had focused primarily on MC for adults.

A cost-effectiveness model was developed and applied to three hypothetical cohorts in Rwanda: newborns, adolescents and adult men. Effectiveness is defined as the number of HIV infections averted, and is the product of the number of people susceptible to HIV infection in the cohort, the HIV incidence rate at different ages and the protective effect of MC; discounted back to the year of circumcision and summed over the life expectancy of the circumcised person. Direct costs were based on interviews with experienced health-care providers to determine inputs involved in the procedure (from consumables to staff time) and related prices. Other costs included training, patient counselling, treatment of adverse events and promotion campaigns and were adjusted for the averted lifetime cost of health care (ART, OI, laboratory tests). One-way sensitivity analysis was performed for different values of the main inputs of the model and the thresholds at which each intervention is (a) no longer cost-saving and (b) at which it costs more than one GDP/capita/life year gained were calculated.

Neonatal male circumcision is less expensive than adolescents and adult male circumcision (15 USD instead of 59 USD per procedure) and is cost-saving (the cost effectiveness ration is negative); even though savings from infant circumcision will be realized later in time. The cost per infection averted is 3,932 USD for adolescent MC and 4,949 USD for adult MC. Results for infant MC appear robust. Infants MC remains highly C-E for a reasonable amount of changes in the base case scenario. Adolescent male circumcision is highly cost-effective for the base case scenario but no longer so for very small changes in the input variables. Adults MC is neither cost-saving nor highly cost-effective when considering only the direct benefit for the circumcised man. Additionally, infant MC can be easily integrated into existing health services (i.e. neonatal visits and vaccination sessions) and has a better potential to achieve the very high coverage over time of the population required for maximal reduction on HIV incidence, than adolescent and adult circumcision.

African leaders and development partners should stop managing the HIV response as an emergency issue and release themselves from a one-year or even a five-year planning perspective to focus on sustainable long-term choices for countries. The study suggests that Rwanda should be simultaneously scaling up circumcision across a broad range of age groups, with highest priority to the very young. In the presence of infant MC, adolescent and adult MC should become a sort of “catch up” campaign that would be needed at the start of the program but would then become superfluous over time.

Rwanda Leads Breakthrough Innovation in HIV Prevention: Male circumcision with no anesthesia, no sutures, no blood and no sterile settings requirement.

Tuesday, March 8, 2001

I had the fantastic opportunity to participate in the Government of Rwanda sponsored study to test the PrePex System, a new device and methododology for rapid adult male circumcision deployment in resource-limited settings.

The study, in line with the World Health Organization’s and UNAIDS’s recommendations to encourage voluntary male circumcision, began in March 2010 and proved the safety and efficacy of the device.

Many studies have proven that circumcised men in high risk areas, including sub-Saharan Africa, reduce their risk of HIV infection by about 60%.

The existing surgical techniques and devices require time of highly trained health professionals, surgical settings and and out of work time for patients to recover. This limits the ability of many African countries to scale up male circumcision initiatives given the regional shortage of health professionals and medical infrastructure and the economic impact of the patient time to recover.

Because we have the conviction that all need to be done to protect our population in the context of the fight against HIV, the Ministry of Health in Rwanda has the national goal to decrease its HIV incidence rate by 50% by circumcising two million adults in two years but so far Current male circumcision efforts have been a drop in the ocean compared to the masses required.

That is why the Ministry of Health of Rwanda, in partnership with the PrePex Compagny a social private entreprise, undertake researches on viable non-surgical male circumcision method. In that context the Government of Rwanda sponsored second clinical study (N°:NCT01284088 on ClinicalTrials.gov) which is showing very promising preliminary results on the cost effectiveness of the use of this new device for HIV prevention, as well as reaffirming our knowledge of the safety and efficacy.
http://clinicaltrials.gov/ct2/show/NCT01150370.

Except for a few hours on the day of deployment, patients circumcised with the PrePex device required no additional recovery days for pain or wound management. This has major economic ramifications for a country like ours, where rural men work their fields and cannot afford to lose so many days of work for a preventative procedure.

The UN press agency wrote about this great development - click here to see the story.